Delivery Order SPE2DR25D2212-SPE2DR26FB9FU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,927.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL dosage) on October 20, 2025, with completion scheduled for October 21, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,142.61 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,237.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen auto-injectors (0.5 mL units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,453.76 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $41,427.70 for Trulicity 1.5 mg/0.5 ml pen injections on October 29, 2025, with completion expected by October 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $5,432.07 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 12, 2025, with completion scheduled for August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $23,260.35 delivery order on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. This is a firm fixed-price, non-set-aside contract with performance through November 5, 2025, and fulfillment from the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,334.91 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 20, 2025. AmerisourceBergen Drug Corp will perform from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9FUDelivery Order
The Defense Logistics Agency awarded a $6,236.72 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections (0.5 ml) with an ultimate completion date of November 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. As prime contractor on the overarching DLA pharmaceutical support vehicle, the company supplies a comprehensive range of medications and medical supplies, including specialty diabetes medications like Trulicity, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The DLA's Pharmaceutical Prime Vendor Global Program is expected to establish Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the primary suppliers for federal pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/10/25 |